Novel nicotine degrading enzyme variants
US-2023416697-A1 · Dec 28, 2023 · US
This page is not indexed by search engines while we improve data quality.
Antidote Therapeutics Inc patents
Antidote Therapeutics Inc holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | Jan 17, 2019 |
| Latest publication | Dec 28, 2023 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Nicotine degrading enzyme variants
US-11597916-B2 · Mar 7, 2023 · US
Novel nicotine degrading enzyme variants
US-2020224176-A1 · Jul 16, 2020 · US
Nicotine-degrading enzymes for treating nicotine addiction and nicotine poisoning
US-2019015484-A1 · Jan 17, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Novel nicotine degrading enzyme variants
US-2023416697-A1 · Dec 28, 2023 · US
Nicotine degrading enzyme variants
US-11597916-B2 · Mar 7, 2023 · US
Novel nicotine degrading enzyme variants
US-2020224176-A1 · Jul 16, 2020 · US
Nicotine-degrading enzymes for treating nicotine addiction and nicotine poisoning
US-2019015484-A1 · Jan 17, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 4 |
| Chemistry & Metallurgy | 4 |